Mol. Cells 2008; 26(5): 486~489  
Curcumin Inhibits Osteoclastogenesis by Decreasing Receptor Activator of Nuclear Factor-kappa B Ligand (RANKL) in Bone Marrow Stromal Cells
Sora Oh, Tae-Wook Kyung and Hye-Seon Choi
© The Korean Society for Molecular and Cellular Biology. All rights reserved.

Curcumin (diferuloylmethane), a pigment derived from turmeric, has anti-oxidant and anti-inflammatory activities. Accumulating evidence points to a biochemical link between increased oxidative stress and reduced bone density. Osteoclast formation was evaluated in co-cultures of bone marrow stromal cells (BMSC) and whole bone marrow cells (BMC). Expression of receptor activator of nuclear factor-kappa B ligand (RANKL) was analyzed at the mRNA and protein levels. Exposure to curcumin led to dose-dependent suppression of osteoclastogenesis in the co-culture system, and to reduced expression of RANKL in IL-1 alpha-stimulated BMSCs. Addition of RANKL abolished the inhibition of osteoclastogenesis by curcumin, whereas the addition of prostaglandin E2 (PGE2) did not. The decreased osteoclastogenesis induced by curcumin may reduce bone loss and be of potential benefit in preventing and/or attenuating osteoporosis.
Keywords: bone, bone marrow stromal cells, curcumin, osteoclastogenesis, receptor activator of nuclear factor-kappa B ligand

Current Issue

30 September 2021 Volume 44,
Number 9, pp. 627~698
COVER PICTURE Non-mitochondrial localization of the N-terminal-deleted mutant form of ACSL1 in Cos7 cells. Green, ACSL1 mutant; Red, mitotracker; Blue, DAPI (Nan et al., pp. 637-646).

Indexed in

  • Science Central
  • CrossMark